Electrophysiology Mapping and Ablation Devices: A Global Strategic Business Report
San Jose, CA (PRWEB) May 02, 2011
Electrophysiology is a specialty area within healthcare that is witnessing rapid growth. Key factors driving this growth include increasing life expectancy, advancement of technologies, and improved knowledge of patients on available procedures. Patients with arrhythmias are primarily treated with medications. However, limited success over the long run, and potential undesirable side effects have increased the need for alternative techniques to provide relief from the condition. One such technique is electrophysiology ablations. Among various types of arrhythmias, Atrial fibrillation has one of the largest incidence and prevalence rates worldwide. Atrial fibrillation affects about 10% of the population above 80 years of age, and 6% of the population over 65 years of age. However, despite the increased prevalence and incidence rates, Atrial fibrillation has historically been less penetrated by electrophysiology devices compared to other areas. Complexity associated with the procedures is cited as one of the key reasons for such low penetration. Aging global population and ineffectiveness of pharmacological treatments have transformed the Atrial fibrillation market into an attractive target for device manufacturers worldwide.
The ablation devices market is expected to witness buoyant growth in the coming few years. Moreover, the industry scenario is changing with the development and introduction of new technologies for ablation-based therapy. The US represents the largest regional market for electrophysiology mapping and ablation devices worldwide, as stated by the new market research report on Electrophysiology Mapping and Ablation Devices. Key market drivers in the US in the near future are expected to be the increasing number of atrial fibrillation treatment procedures, as well as the increasing use of the highly priced Intra-Cardiac Echocardiography (ICE) and mapping catheters. Europe trails behind the US market for electrophysiology mapping and ablation devices, while growth in the market would be led by Asia-Pacific, which is projected to be the fastest growing regional market during the analysis period. Segment-wise, Electrophysiology Ablation Catheters represent the largest segment, while Electrophysiology Mapping Catheters is expected to be the fastest growing product type.
Intra-Cardiac Echocardiography (ICE) diagnostic catheters, used for ablation and interventional cardiology procedures, represent the fastest growing segment in US electrophysiology market. Further, the growing preference for irrigated ablation catheters by physicians is causing a decline in the market for non-irrigated radiofrequency ablation catheters. Manual steering has been the most widely used mechanism for conducting catheter ablation procedures, while robotic catheter or remote magnetic guidance was utilized in comparatively less number of procedures. Despite of the various advantages of robotic guidance, higher system costs and catheter compatibility issues restricted the wider use of robotic guidance system. On the other hand, remote magnetic navigation also suffered from limited use in the recent years owing to the high cost involved in renovating the room settings to accommodate the required equipment.
Major players profiled in the report include Arrow International Inc., AtriCure Inc., Biosense Webster Inc., Boston Scientific Corp., C.R. Bard Inc., Endosense SA, Hansen Medical Inc., Medtronic Inc., St. Jude Medical Inc., Stereotaxis, among others.
The research report titled “Electrophysiology Mapping and Ablation Devices: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the electrophysiology mapping and ablation devices markets, current market trends, key growth drivers, recent product approvals, recent industry activity, and profiles of major/niche global as well as regional market participants. The report provides annual sales estimates and projections for electrophysiology mapping and ablation devices market for the years 2009 through 2017 for the following geographic markets - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. The report analyzes the global as well as regional markets by the following segments - Electrophysiology Mapping Catheters, and Electrophysiology Ablation Catheters. Also, a six-year (2003-2008) historic analysis is provided for additional perspective.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Electrophysiology_Mapping_and_Ablation_Devices_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/